BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1535177)

  • 1. Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
    Bloch M; Adam S; Wiggins S; Huggins M; Hayden MR
    Am J Med Genet; 1992 Feb; 42(4):499-507. PubMed ID: 1535177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
    Huggins M; Bloch M; Wiggins S; Adam S; Suchowersky O; Trew M; Klimek M; Greenberg CR; Eleff M; Thompson LP
    Am J Med Genet; 1992 Feb; 42(4):508-15. PubMed ID: 1535178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Cassiman JJ; Cloostermans T; Demyttenaere K; Dom R; Fryns JP
    J Med Genet; 1999 Dec; 36(12):897-905. PubMed ID: 10593997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term impact of Huntington disease linkage testing.
    Taylor CA; Myers RH
    Am J Med Genet; 1997 Jun; 70(4):365-70. PubMed ID: 9182776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological costs and benefits of predictive testing for Huntington's disease.
    Codori AM; Brandt J
    Am J Med Genet; 1994 Sep; 54(3):174-84. PubMed ID: 7810575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of 14 individuals who requested predictive genetic testing for hereditary neuromuscular diseases].
    Yoshida K; Tamai M; Kubota T; Kawame H; Amano N; Ikeda S; Fukushima Y
    Rinsho Shinkeigaku; 2002 Feb; 42(2):113-7. PubMed ID: 12424959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
    Tibben A; Frets PG; van de Kamp JJ; Niermeijer MF; Vegtervan der Vlis M; Roos RA; Rooymans HG; van Ommen GJ; Verhage F
    Am J Med Genet; 1993 Jul; 48(2):103-11. PubMed ID: 8362926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program.
    Bloch M; Adam S; Fuller A; Kremer B; Welch JP; Wiggins S; Whyte P; Huggins M; Theilmann J; Hayden MR
    Am J Med Genet; 1993 Sep; 47(3):368-74. PubMed ID: 8135283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological distress in the 5-year period after predictive testing for Huntington's disease.
    Decruyenaere M; Evers-Kiebooms G; Cloostermans T; Boogaerts A; Demyttenaere K; Dom R; Fryns JP
    Eur J Hum Genet; 2003 Jan; 11(1):30-8. PubMed ID: 12529703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.
    Bloch M; Fahy M; Fox S; Hayden MR
    Am J Med Genet; 1989 Feb; 32(2):217-24. PubMed ID: 2522735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilemmas of anonymous predictive testing for Huntington disease: privacy vs. optimal care.
    Burgess MM; Adam S; Bloch M; Hayden MR
    Am J Med Genet; 1997 Aug; 71(2):197-201. PubMed ID: 9217222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes of persons at risk for Huntington disease toward predictive testing.
    Kessler S; Field T; Worth L; Mosbarger H
    Am J Med Genet; 1987 Feb; 26(2):259-70. PubMed ID: 2949610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychosocial aspects in presymptomatic testing for genetic diseases. Experiences after 2 years of counseling in Huntington disease].
    Blomhoff S; Malt U; Weisaeth L
    Tidsskr Nor Laegeforen; 1995 Jan; 115(1):27-9. PubMed ID: 7846655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive testing for Huntington's disease.
    Tibben A
    Brain Res Bull; 2007 Apr; 72(2-3):165-71. PubMed ID: 17352941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders.
    Smith CO; Lipe HP; Bird TD
    Arch Neurol; 2004 Jun; 61(6):875-80. PubMed ID: 15210524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian experience with predictive testing for Huntington disease: lessons for genetic testing centers and policy makers.
    Chapman MA
    Am J Med Genet; 1992 Feb; 42(4):491-8. PubMed ID: 1535176
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutation.
    Bombard Y; Penziner E; Decolongon J; Klimek ML; Creighton S; Suchowersky O; Guttman M; Paulsen JS; Bottorff JL; Hayden MR
    Clin Genet; 2007 Mar; 71(3):220-31. PubMed ID: 17309644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-selection in predictive testing for Huntington's disease.
    Codori AM; Hanson R; Brandt J
    Am J Med Genet; 1994 Sep; 54(3):167-73. PubMed ID: 7810574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Philippe K; Demyttenaere K; Dom R; Vandenberghe W; Fryns JP
    Eur J Hum Genet; 2007 Apr; 15(4):453-62. PubMed ID: 17245406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Predictive diagnostics in chorea huntington: psychotherapeutic implications for counselling].
    Richartz-Salzburger E; Mau-Holzmann U; Schott KJ; Buchkremer G
    Psychiatr Prax; 2006 Jul; 33(5):211-7. PubMed ID: 16802259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.